CTOs on the Move

Senomyx

www.senomyx.com

 
Senomyx is using proprietary taste science technologies to discover, develop, and commercialize novel flavor ingredients.  These include modifiers of Sweet and Salt flavors as well as Savory Flavors, Bitter Blockers, and Cooling Agents.  The Company is also engaged in an effort to discover and develop natural high-potency sweeteners.  Under its direct sales program, Senomyx is beginning to sell certain of its Complimyx brand flavor ingredients, Sweetmyx, Savorymyx, and Bittermyx, to flavor companies for re-sale to their food and beverage company customers.  In addition, Senomyx has collaborative agreements with global food, beverage, and ingredient supply companies, some of which are currently ...
  • Number of Employees: 100-250
  • Annual Revenue: $10-50 Million
  • www.senomyx.com
  • 4767 Nexus Center Dr
    San Diego, CA USA 92121
  • Phone: 858.646.8300

Executives

Name Title Contact Details

Similar Companies

Comprehensive NeuroScience

Comprehensive NeuroScience, Inc. is a Hollywood, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

AFB International

AFB International is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Saint Charles, MO. To find more information about AFB International, please visit www.afbinternational.com

Functional Pathways

Functional Pathways is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Knoxville, TN. To find more information about Functional Pathways, please visit www.fprehab.com

OncoCell MDx

OncoCellMDx is a privately held company dedicated to the development and commercialization of novel diagnostic tests utilizing proprietary technologies created at Harvard Medical School. In particular, we have developed a noninvasive blood-based immunogenomic assays that will aid the physician to better understand the underlying pathology. The first product is for assessing the severity of prostate cancer. Other oncology indications as well as non-oncology indications are part of our pipeline. The assay is based on examining specific transcription levels between phagocytic and non-phagocytic cells. This proprietary technology and algorithm has allowed us to not only detect disease but to also, and more importantly, guide the physician as to the grade and aggressiveness of the disease. Our mission is to provide clinicians with quantifiable results that allows professionals to make timely and much more directed medical decisions.

Rocky Mountain Health Plans

Rocky Mountain Health Plans is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Grand Junction, CO. To find more information about Rocky Mountain Health Plans, please visit www.rmhp.org